Finance

Lists
Why is LABS up 9.09%?
Dive Deeper
LABS:TSE
Medipharm Labs Corp
CA$0.060
+9.09%
(+0.0050) 1D
Nov 20, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LABS...
Open
CA$0.06
High
CA$0.06
Low
CA$0.06
Mkt. cap
25.63M
Avg. vol.
164.09K
Volume
132.60K
52-wk high
CA$0.10
52-wk low
CA$0.06
EPS
-CA$0.01
Beta
0.47
Shares outstanding
427.18M
No. of employees
127
Open
CA$0.06
High
CA$0.06
Low
CA$0.06
Mkt. cap
25.63M
Avg. vol.
164.09K
Volume
132.60K
52-wk high
CA$0.10
52-wk low
CA$0.06
EPS
-CA$0.01
Beta
0.47
Shares outstanding
427.18M
No. of employees
127
News stories
From web sources and news partners
About Medipharm Labs Corp
CEO-
Employees127
Founded2015
HeadquartersBarrie, Ontario, Canada
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 12, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (CAD)
11.80M / 10.18M
+15.97%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
11.06M
8.96M
9.98M
11.80M
Cost of goods sold
7.29M
5.65M
5.56M
8.00M
Cost of revenue
7.29M
5.65M
5.56M
8.00M
Research and development expenses
52.00K
24.00K
83.00K
16.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.40M
4.28M
3.93M
3.57M
Operating expense
4.77M
4.30M
4.35M
3.73M
Total operating expenses
12.06M
9.96M
9.90M
11.72M
Operating income
-998.00K
-994.00K
82.00K
79.00K
Other non operating income
-
-
-
-
EBT including unusual items
-1.97M
-867.00K
4.00K
112.00K
EBT excluding unusual items
-996.00K
-867.00K
120.00K
112.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
358.00K
-2.00K
-110.00K
39.00K
Net income
-1.97M
-867.00K
4.00K
112.00K
Net profit margin
-17.79%
-9.67%
0.04%
0.95%
Earnings per share
-
-
-
-
Interest and investment income
58.00K
60.00K
50.00K
47.00K
Interest expense
-19.00K
-15.00K
-12.00K
-14.00K
Net interest expenses
39.00K
45.00K
38.00K
33.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-611.00K
-621.00K
458.00K
410.00K
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps